Answers are grounded in this paper and cite their sources.
Amyloidosis in the absence of neurodegeneration did not have an adverse impact on practice effects or the 30-month cognitive trajectories. In contrast, participants with neurodegeneration (either A-N+ or A+N+) had worse performance at the 30-month follow-up. Our results show that neurodegeneration has a more deleterious effect on cognition than amyloidosis in clinically normal individuals.
No takes yet. Share an insight, caveat, or question.
Machulda et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: